1887
  1. Home
  2. Eurosurveillance
  3. Volume 31, Issue 26, 02/Jul/2026
  4. Article
Research Open Access
Like 0
Download

Abstract

BACKGROUND

West Nile virus (WNV) is an orthoflavivirus maintained in an enzootic cycle between birds and ornithophilic mosquitoes. Human infections are usually asymptomatic or paucisymptomatic, while severe neurological disease occurs mainly in children, elderly and immunocompromised individuals. Despite evidence of WNV circulation in France since the 1960s, nationwide seroprevalence data are unavailable.

AIM

We wanted to determine the seroprevalence of WNV among blood donors in mainland France to characterise the epidemiology of WNV and assess risk factors and potential implications for transfusion safety and public health.

METHODS

Sera from 44,490 volunteer blood donors collected in 2021–2022 in France were screened for anti-WNV IgG by ELISA on pools of up to four samples, with samples from non-negative pools tested individually. ELISAs for various flaviviruses and virus neutralisation tests were used to assess non-negative results.

RESULTS

Seroprevalence was low overall, similar in pools and individual samples (0.87% and 0.97%, respectively). Prevalence was 1.13% in Nouvelle-Aquitaine and 1.81% in Ile-de-France, preceding the first local human cases reported in 2023 and 2025 in these regions, respectively. The risk factors identified as being associated with WNV seropositivity were geographic (living in the south of France: Occitanie, Provence-Alpes-Côte d'Azur and Corsica) and related to ABO blood group.

CONCLUSION

Seroprevalence of West Nile virus in France is low but variable, suggesting that WNV may have circulated undetected in some areas. Monitoring flavivirus prevalence in blood donors can serve as an early warning system for human infections and provide valuable data for public health preparedness.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2026.31.26.2500808
2026-07-02
2026-07-18
/content/10.2807/1560-7917.ES.2026.31.26.2500808
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/31/26/eurosurv-31-26-1.html?itemId=/content/10.2807/1560-7917.ES.2026.31.26.2500808&mimeType=html&fmt=ahah

References

  1. Simonin Y. Circulation of West Nile Virus and Usutu Virus in Europe: Overview and Challenges. Viruses. 2024;16(4):599.  https://doi.org/10.3390/v16040599  PMID: 38675940 
  2. Wheeler SS, Barker CM, Fang Y, Armijos MV, Carroll BD, Husted S, et al. Differential impact of West Nile Virus on California birds. Condor. 2009;111(1):1-20.  https://doi.org/10.1525/cond.2009.080013  PMID: 20589226 
  3. Komar N, Langevin S, Hinten S, Nemeth N, Edwards E, Hettler D, et al. Experimental infection of North American birds with the New York 1999 strain of West Nile virus. Emerg Infect Dis. 2003;9(3):311-22.  https://doi.org/10.3201/eid0903.020628  PMID: 12643825 
  4. Kilpatrick AM, Daszak P, Jones MJ, Marra PP, Kramer LD. Host heterogeneity dominates West Nile virus transmission. Proc Biol Sci. 2006;273(1599):2327-33.  https://doi.org/10.1098/rspb.2006.3575  PMID: 16928635 
  5. Maquart M, Dahmani M, Marié JL, Gravier P, Leparc-Goffart I, Davoust B. First Serological Evidence of West Nile Virus in Horses and Dogs from Corsica Island, France. Vector Borne Zoonotic Dis. 2017;17(4):275-7.  https://doi.org/10.1089/vbz.2016.2024  PMID: 28075236 
  6. Kuchinsky SC, Duggal NK. Usutu virus, an emerging arbovirus with One Health importance. Adv Virus Res. 2024;120:39-75.  https://doi.org/10.1016/bs.aivir.2024.09.002  PMID: 39455168 
  7. Pealer LN, Marfin AA, Petersen LR, Lanciotti RS, Page PL, Stramer SL, et al. , West Nile Virus Transmission Investigation Team. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med. 2003;349(13):1236-45.  https://doi.org/10.1056/NEJMoa030969  PMID: 14500806 
  8. Iwamoto M, Jernigan DB, Guasch A, Trepka MJ, Blackmore CG, Hellinger WC, et al. , West Nile Virus in Transplant Recipients Investigation Team. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med. 2003;348(22):2196-203.  https://doi.org/10.1056/NEJMoa022987  PMID: 12773646 
  9. Hayes EB, O’Leary DR. West Nile virus infection: a pediatric perspective. Pediatrics. 2004;113(5):1375-81.  https://doi.org/10.1542/peds.113.5.1375  PMID: 15121956 
  10. Centers for Disease Control and Prevention (CDC). West Nile virus. Symptoms, diagnosis and treatment. Atlanta: CDC. [Accessed: 5 Jun 2025]. Available from: https://www.cdc.gov/west-nile-virus/symptoms-diagnosis-treatment/index.html
  11. Joubert L, Oudar J, Hannoun C, Beytout D, Corniou B, Guillon JC, et al. [Epidemiology of the West Nile virus: study of a focus in Camargue. IV. Meningo-encephalomyelitis of the horse]. Ann Inst Pasteur (Paris). 1970;118(2):239-47. PMID: 5461277 
  12. Durand B, Chevalier V, Pouillot R, Labie J, Marendat I, Murgue B, et al. West Nile virus outbreak in horses, southern France, 2000: results of a serosurvey. Emerg Infect Dis. 2002;8(8):777-82.  https://doi.org/10.3201/eid0808.010486  PMID: 12141961 
  13. Zeller H, Zientara S, Hars J, Languille J, Mailles A, Tolou H, et al. West Nile outbreak in horses in Southern France: September 2004. Euro Surveill. 2004;8(41):2564.  https://doi.org/10.2807/esw.08.41.02564-en 
  14. Pozzetto B, Grard G, Durand G, Paty MC, Gallian P, Lucas-Samuel S, et al. Arboviral Risk Associated with Solid Organ and Hematopoietic Stem Cell Grafts: The Prophylactic Answers Proposed by the French High Council of Public Health in a National Context. Viruses. 2023;15(9):1783.  https://doi.org/10.3390/v15091783  PMID: 37766192 
  15. Santé publique France (SPF). Chikungunya, dengue virus, West Nile et zika en Nouvelle-Aquitaine. Point au 6 juin 2024. [Chikungunya, dengue, West Nile virus and Zika in Nouvelle-Aquitaine. Situation as of June 6, 2024]. Paris: SPF; 2024. French. Available from: https://www.santepubliquefrance.fr/regions/nouvelle-aquitaine/documents/bulletin-regional/2024/chikungunya-dengue-virus-west-nile-et-zika-en-nouvelle-aquitaine.-point-au-6-juin-2024
  16. Hassold-Rugolino N, Jaquet P, Da Silva D, Papa E, Calmettes J, Henry C, et al. Two Cases of Autochthonous West Nile Virus Encephalitis, Paris, France, 2025. Emerg Infect Dis. 2025;31(11):2172-4.  https://doi.org/10.3201/eid3111.251220  PMID: 40833786 
  17. Santé publique France (SPF). Surveillance sanitaire en Ile-de-France. Bulletin du 27 août 2025. Health monitoring in Ile-de-France. Bulletin of August 27, 2025]. Paris: SPF; 2025. French. Available from: https://www.santepubliquefrance.fr/regions/ile-de-france/documents/bulletin-regional/2025/surveillance-sanitaire-en-ile-de-france.-bulletin-du-27-aout-2025
  18. Constant O, Gil P, Barthelemy J, Bolloré K, Foulongne V, Desmetz C, et al. One Health surveillance of West Nile and Usutu viruses: a repeated cross-sectional study exploring seroprevalence and endemicity in Southern France, 2016 to 2020. Euro Surveill. 2022;27(25):2200068.  https://doi.org/10.2807/1560-7917.ES.2022.27.25.2200068  PMID: 35748300 
  19. Nurtop E, Villarroel PMS, Pastorino B, Ninove L, Drexler JF, Roca Y, et al. Combination of ELISA screening and seroneutralisation tests to expedite Zika virus seroprevalence studies. Virol J. 2018;15(1):192.  https://doi.org/10.1186/s12985-018-1105-5  PMID: 30587193 
  20. Inchauste L, Nurtop E, Brisbarre N, Ninove L, Gallian P, de Lamballerie X, et al. Exploring cell-free assays for COVID-19 serosurvey. Sci Rep. 2024;14(1):6096.  https://doi.org/10.1038/s41598-024-55852-6  PMID: 38480769 
  21. Charrel RN, de Lamballerie X, Durand JP, Gallian P, Attoui H, Biagini P, et al. Prevalence of antibody against West Nile virus in volunteer blood donors living in southeastern France. Transfusion. 2001;41(10):1320-1.  https://doi.org/10.1046/j.1537-2995.2001.41101320.x  PMID: 11606836 
  22. Rocha R, Kurum E, Charrel R, Ayhan N, Maia C. Seroprevalence of West Nile Virus in Blood Donors in Mainland Portugal. Trop Med Infect Dis. 2025;10(8):229.  https://doi.org/10.3390/tropicalmed10080229  PMID: 40864132 
  23. Faggioni G, De Santis R, Pomponi A, Grottola A, Serpini GF, Meacci M, et al. Prevalence of Usutu and West Nile virus antibodies in human sera, Modena, Italy, 2012. J Med Virol. 2018;90(10):1666-8.  https://doi.org/10.1002/jmv.25230  PMID: 29797606 
  24. Pierro A, Gaibani P, Spadafora C, Ruggeri D, Randi V, Parenti S, et al. Detection of specific antibodies against West Nile and Usutu viruses in healthy blood donors in northern Italy, 2010-2011. Clin Microbiol Infect. 2013;19(10):E451-3.  https://doi.org/10.1111/1469-0691.12241  PMID: 23663225 
  25. Amendola A, Boros S, Pati I, Lombardini L, Fiorentini C, Fortuna C, et al. Seroprevalence study of West Nile virus and Usutu virus in blood, organs, cells and tissue donors in Italy. Blood Transfus. 2021-2022;2025(Sept):5. PMID: 41037322 
  26. Pezzotti P, Piovesan C, Barzon L, Cusinato R, Cattai M, Pacenti M, et al. Prevalence of IgM and IgG antibodies to West Nile virus among blood donors in an affected area of north-eastern Italy, summer 2009. Euro Surveill. 2011;16(10):19814.  https://doi.org/10.2807/ese.16.10.19814-en  PMID: 21435323 
  27. Gaibani P, Pierro A, Lunghi G, Farina C, Toschi V, Matinato C, et al. Seroprevalence of West Nile virus antibodies in blood donors living in the metropolitan area of Milan, Italy, 2009-2011. New Microbiol. 2013;36(1):81-3. PMID: 23435819 
  28. Pierro A, Gaibani P, Manisera C, Dirani G, Rossini G, Cavrini F, et al. Seroprevalence of West Nile virus-specific antibodies in a cohort of blood donors in northeastern Italy. Vector Borne Zoonotic Dis. 2011;11(12):1605-7.  https://doi.org/10.1089/vbz.2011.0616  PMID: 21867418 
  29. Burki T. Increase of West Nile virus cases in Europe for 2018. Lancet. 2018;392(10152):1000.  https://doi.org/10.1016/S0140-6736(18)32286-4  PMID: 30264694 
  30. Shirai Y, Funada H, Seki T, Morohashi M, Kamimura K. Landing preference of Aedes albopictus (Diptera: Culicidae) on human skin among ABO blood groups, secretors or nonsecretors, and ABH antigens. J Med Entomol. 2004;41(4):796-9.  https://doi.org/10.1603/0022-2585-41.4.796  PMID: 15311477 
  31. Liao Y, Xue L, Gao J, Wu A, Kou X. ABO blood group-associated susceptibility to norovirus infection: A systematic review and meta-analysis. Infect Genet Evol. 2020;81:104245.  https://doi.org/10.1016/j.meegid.2020.104245  PMID: 32092482 
  32. Frenken P, Hartung HP, Olsson T, Adams O, Warnke C. Type O blood group associates with higher anti-JC polyomavirus antibody levels. Brain Behav. 2021;11(8):e2298.  https://doi.org/10.1002/brb3.2298  PMID: 34291599 
  33. Arend P. Why blood group A individuals are at risk whereas blood group O individuals are protected from SARS-CoV-2 (COVID-19) infection: A hypothesis regarding how the virus invades the human body via ABO(H) blood group-determining carbohydrates. Immunobiology. 2021;226(3):152027.  https://doi.org/10.1016/j.imbio.2020.152027  PMID: 33706067 
  34. Wang H, Zhang J, Jia L, Ai J, Yu Y, Wang M, et al. ABO blood group influence COVID-19 infection: a meta-analysis. J Infect Dev Ctries. 2021;15(12):1801-7.  https://doi.org/10.3855/jidc.13815  PMID: 35044935 
  35. Deschasaux-Tanguy M, Szabo de Edelenyi F, Druesne-Pecollo N, Esseddik Y, Allègre J, Srour B, et al. , SAPRIS-SERO study group. ABO blood types and SARS-CoV-2 infection assessed using seroprevalence data in a large population-based sample: the SAPRIS-SERO multi-cohort study. Sci Rep. 2023;13(1):4775.  https://doi.org/10.1038/s41598-023-30714-9  PMID: 36959255 
  36. Gallian P, Pastorino B, Morel P, Chiaroni J, Ninove L, de Lamballerie X. Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors. Antiviral Res. 2020;181:104880.  https://doi.org/10.1016/j.antiviral.2020.104880  PMID: 32679056 
  37. Batool Z, Durrani SH, Tariq S. Association Of Abo And Rh Blood Group Types To Hepatitis B, Hepatitis C, Hiv And Syphilis Infection, A Five Year’ Experience In Healthy Blood Donors In A Tertiary Care Hospital. J Ayub Med Coll Abbottabad. 2017;29(1):90-2. PMID: 28712183 
  38. Cong X, Li HB, Sun XM, Qi JX, Zhang Q, Duan ZJ, et al. Functional and structural characterization of Norovirus GII.6 in recognizing histo-blood group antigens. Virol Sin. 2023;38(1):56-65.  https://doi.org/10.1016/j.virs.2022.09.010  PMID: 36216242 
  39. Kaidarova Z, Bravo MD, Kamel HT, Custer BS, Busch MP, Lanteri MC. Blood group A and D negativity are associated with symptomatic West Nile virus infection. Transfusion. 2016;56(7):1699-706.  https://doi.org/10.1111/trf.13622  PMID: 27189860 
  40. Politis C, Parara M, Kremastinou J, Hasapopoulou E, Iniotaki A, Siorenta A, et al. Associations of ABO, D, and Lewis blood groups and HLA Class I and Class II alleles with West Nile virus Lineage 2 disease outcome in Greece, 2010 to 2013. Transfusion. 2016;56(8):2115-21.  https://doi.org/10.1111/trf.13667  PMID: 27245377 
  41. Pacenti M, Sinigaglia A, Franchin E, Pagni S, Lavezzo E, Montarsi F, et al. Human West Nile Virus Lineage 2 Infection: Epidemiological, Clinical, and Virological Findings. Viruses. 2020;12(4):458.  https://doi.org/10.3390/v12040458  PMID: 32325716 
  42. Koureas M, Nasika A, Lianos AG, Vontas A, Kyritsi MA, Voulgaridi I, et al. Seroprevalence of West Nile virus, Greece, 2020. Euro Surveill. 2025;30(15):2400487.  https://doi.org/10.2807/1560-7917.ES.2025.30.15.2400487  PMID: 40248889 
Seroprevalence of West Nile virus among blood donors in mainland France, 2021 to 2022
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Pauline+Jourdan&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Jourdan Pauline</a>, <a href="/search?value1=Karine+Barth%C3%A9l%C3%A9my&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Barthélémy Karine</a>, <a href="/search?value1=Nad%C3%A8ge+Brisbarre&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Brisbarre Nadège</a>, <a href="/search?value1=Christine+Isnard&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Isnard Christine</a>, <a href="/search?value1=Pierre+Gallian&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Gallian Pierre</a>, <a href="/search?value1=St%C3%A9phane+Priet&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Priet Stéphane</a>, <a href="/search?value1=Xavier+de+Lamballerie&option1=author&noRedirect=true" class="nonDisambigAuthorLink">de Lamballerie Xavier</a></span>. Seroprevalence of West Nile virus among blood donors in mainland France, 2021 to 2022. <a href="/content/ecdc">Euro Surveill.</a> 2026;31(26):pii=2500808. <a href="https://doi.org/10.2807/1560-7917.ES.2026.31.26.2500808" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2026.31.26.2500808</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 21 Oct 2025;&nbsp;&nbsp; <span class="generated">Accepted</span>: 02 Feb 2026 </span> </p>
/content/10.2807/1560-7917.ES.2026.31.26.2500808
/content/10.2807/1560-7917.ES.2026.31.26.2500808
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error